Patients diagnoised with basal cells carcinoma, also known as skin cancer , will be enrolled to evaluate new treatments for this skin cancer. Clinical trial participants will be monitored closely by medical professionals for the duration of the study. The goal of this basel cell carcinoma clinical trial is to develop better understanding of basel cell carcinoma and develop safe and effective therapies.
14 weeks to 16 weeks depending on study
Subject compensation and travel assistance may be available. Study medication, study related exams, and lab tests will be provided at no cost.
For general questions regarding our clinical trials, please contact our team at clinicaltrials@clearlyderm.com or fill out the contact form below.
Looking to visit a dermatologist? Click the button below to schedule an appointment with our team of skin experts.